Recently Featured
scientist working with gene therapy

Novartis Reports Tumors Possibly Linked to Zolgensma Treatment

November 6, 2026
Novartis has acknowledged seven previously unknown instances of tumors found in children treated with its spinal muscular atrophy therapy, Zolgensma. This development has raised concerns among families, physicians, and patient advocacy groups. The cases are currently regarded as a potential safety signal and were publicized by an advocacy group and on a Facebook page after…
Laboratory scene with gene therapy research

Orphan Therapeutics Accelerator In-Licenses OTXL-101 for OTCD

November 6, 2026
Orphan Therapeutics Accelerator (OTXL) has in-licensed an investigational therapy program for ornithine transcarbamylase deficiency (OTCD), a rare metabolic disorder. The therapy, now named OTXL-101, was previously known as AAVLK03hOTC and developed through collaborations at University College London and Children’s Medical Research Institute. This marks OTXL’s first in-licensed therapy. The nonprofit biotech aims to revitalize shelved…
Peptide manufacturing equipment in a lab

Shilpa CDMO Invests $50 Million to Expand Peptide Manufacturing Capacity

November 6, 2026
Shilpa CDMO is committing $50 million to expand its peptide manufacturing infrastructure in India. The investment will add production capacity and specialized capabilities to support growing demand for GLP-1 drugs and complex peptide-based therapeutics. The expansion will be implemented in phases over the next several years, adding 10 kiloliters (KL) of solid-phase peptide synthesis (SPPS)…
Scientist working in a laboratory

Emvena Therapeutics Launches to Develop Preeclampsia Treatment

November 6, 2026
Emvena Therapeutics has emerged from stealth with backing from the Penn-BioNTech Innovative Therapeutics Seed Fund to advance an experimental approach to treating preeclampsia, a pregnancy complication that can pose serious risks to both mothers and babies. The Philadelphia-based biotechnology company was co-founded by Kelsey Swingle, an assistant professor of bioengineering at Rice University, and is…

Ongoing Cases